{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:52:39Z","timestamp":1790833959958,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,9,11]],"date-time":"2017-09-11T00:00:00Z","timestamp":1505088000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2017,9,11]],"date-time":"2017-09-11T00:00:00Z","timestamp":1505088000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1054404"],"award-info":[{"award-number":["OPP1054404"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1164105"],"award-info":[{"award-number":["OPP1164105"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12936-017-2017-3","type":"journal-article","created":{"date-parts":[[2017,9,11]],"date-time":"2017-09-11T13:04:50Z","timestamp":1505135090000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Methods for the field evaluation of quantitative G6PD diagnostics: a review"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5734-0845","authenticated-orcid":false,"given":"Benedikt","family":"Ley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Germana","family":"Bancone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenz","family":"von Seidlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamala","family":"Thriemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack S.","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo J.","family":"Domingo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ric N.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,11]]},"reference":[{"key":"2017_CR1","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0140-6736(08)60073-2","volume":"371","author":"MD Cappellini","year":"2008","unstructured":"Cappellini MD, Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet. 2008;371:64\u201374.","journal-title":"Lancet"},{"key":"2017_CR2","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/1475-2875-12-112","volume":"12","author":"L von Seidlein","year":"2013","unstructured":"von Seidlein L, Auburn S, Espino F, Shanks D, Cheng Q, McCarthy J, et al. Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop report. Malar J. 2013;12:112.","journal-title":"Malar J"},{"key":"2017_CR3","first-page":"CD004389","volume":"10","author":"GN Galappaththy","year":"2013","unstructured":"Galappaththy GN, Tharyan P, Kirubakaran R. Primaquine for preventing relapse in people with Plasmodium vivax malaria treated with chloroquine. Cochrane Database Syst Rev. 2013;10:CD004389.","journal-title":"Cochrane Database Syst Rev"},{"key":"2017_CR4","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1186\/1475-2875-12-418","volume":"12","author":"RE Howes","year":"2013","unstructured":"Howes RE, Dewi M, Piel FB, Monteiro WM, Battle KE, Messina JP, et al. Spatial distribution of G6PD deficiency variants across malaria-endemic regions. Malar J. 2013;12:418.","journal-title":"Malar J"},{"key":"2017_CR5","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1126\/science.1178849","volume":"326","author":"C Louicharoen","year":"2009","unstructured":"Louicharoen C, Patin E, Paul R, Nuchprayoon I, Witoonpanich B, Peerapittayamongkol C, et al. Positively selected G6PD-Mahidol mutation reduces Plasmodium vivax density in Southeast Asians. Science. 2009;326:1546\u20139.","journal-title":"Science"},{"key":"2017_CR6","doi-asserted-by":"publisher","first-page":"e0165340","DOI":"10.1371\/journal.pone.0165340","volume":"11","author":"Z Pava","year":"2016","unstructured":"Pava Z, Burdam FH, Handayuni I, Trianty L, Utami RA, Tirta YK, et al. Submicroscopic and asymptomatic Plasmodium parasitaemia associated with significant risk of anaemia in Papua, Indonesia. PLoS ONE. 2016;11:e0165340.","journal-title":"PLoS ONE"},{"key":"2017_CR7","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1093\/trstmh\/trt015","volume":"107","author":"MS Santana","year":"2013","unstructured":"Santana MS, Monteiro WM, Siqueira AM, Costa MF, Sampaio V, Lacerda MV, et al. Glucose-6-phosphate dehydrogenase deficient variants are associated with reduced susceptibility to malaria in the Brazilian Amazon. Trans R Soc Trop Med Hyg. 2013;107:301\u20136.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2017_CR8","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/1475-2875-12-171","volume":"12","author":"N Khim","year":"2013","unstructured":"Khim N, Benedet C, Kim S, Kheng S, Siv S, Leang R, et al. G6PD deficiency in Plasmodium falciparum and Plasmodium vivax malaria-infected Cambodian patients. Malar J. 2013;12:171.","journal-title":"Malar J"},{"key":"2017_CR9","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1086\/432519","volume":"77","author":"DP Kwiatkowski","year":"2005","unstructured":"Kwiatkowski DP. How malaria has affected the human genome and what human genetics can teach us about malaria. Am J Hum Genet. 2005;77:171\u201392.","journal-title":"Am J Hum Genet"},{"key":"2017_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12936-015-1045-0","volume":"15","author":"SS Shah","year":"2016","unstructured":"Shah SS, Rockett KA, Jallow M, Sisay-Joof F, Bojang KA, Pinder M, et al. Heterogeneous alleles comprising G6PD deficiency trait in West Africa exert contrasting effects on two major clinical presentations of severe malaria. Malar J. 2016;15:13.","journal-title":"Malar J"},{"key":"2017_CR11","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/1475-2875-11-280","volume":"11","author":"GK John","year":"2012","unstructured":"John GK, Douglas NM, von Seidlein L, Nosten F, Baird JK, White NJ, et al. Primaquine radical cure of Plasmodium vivax: a critical review of the literature. Malar J. 2012;11:280.","journal-title":"Malar J"},{"key":"2017_CR12","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1186\/1475-2875-13-418","volume":"13","author":"EA Ashley","year":"2014","unstructured":"Ashley EA, Recht J, White NJ. Primaquine: the risks and the benefits. Malar J. 2014;13:418.","journal-title":"Malar J"},{"key":"2017_CR13","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1080\/14787210.2016.1220304","volume":"14","author":"CS Chu","year":"2016","unstructured":"Chu CS, White NJ. Management of relapsing Plasmodium vivax malaria. Expert Rev Anti Infect Ther. 2016;14:885\u2013900.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2017_CR14","first-page":"9","volume":"42","author":"W Maneeboonyang","year":"2011","unstructured":"Maneeboonyang W, Lawpoolsri S, Puangsa-Art S, Yimsamran S, Thanyavanich N, Wuthisen P, et al. Directly observed therapy with primaquine to reduce the recurrence rate of Plasmodium vivax infection along the Thai-Myanmar border. Southeast Asian J Trop Med Public Health. 2011;42:9\u201318.","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"2017_CR15","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1186\/1475-2875-10-355","volume":"10","author":"EA Pereira","year":"2011","unstructured":"Pereira EA, Ishikawa EA, Fontes CJ. Adherence to Plasmodium vivax malaria treatment in the Brazilian Amazon Region. Malar J. 2011;10:355.","journal-title":"Malar J"},{"key":"2017_CR16","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/1475-2875-9-308","volume":"9","author":"R Takeuchi","year":"2010","unstructured":"Takeuchi R, Lawpoolsri S, Imwong M, Kobayashi J, Kaewkungwal J, Pukrittayakamee S, et al. Directly-observed therapy (DOT) for the radical 14-day primaquine treatment of Plasmodium vivax malaria on the Thai-Myanmar border. Malar J. 2010;9:308.","journal-title":"Malar J"},{"key":"2017_CR17","first-page":"CD010458","volume":"4","author":"S Rajapakse","year":"2015","unstructured":"Rajapakse S, Rodrigo C, Fernando SD. Tafenoquine for preventing relapse in people with Plasmodium vivax malaria. Cochrane Database Syst Rev. 2015;4:CD010458.","journal-title":"Cochrane Database Syst Rev"},{"key":"2017_CR18","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1093\/infdis\/jiv508","volume":"213","author":"HP Beck","year":"2016","unstructured":"Beck HP, Wampfler R, Carter N, Koh G, Osorio L, Rueangweerayut R, et al. Estimation of the antirelapse efficacy of tafenoquine, using Plasmodium vivax genotyping. J Infect Dis. 2016;213:794\u20139.","journal-title":"J Infect Dis"},{"key":"2017_CR19","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/S0140-6736(13)62568-4","volume":"383","author":"A Llanos-Cuentas","year":"2014","unstructured":"Llanos-Cuentas A, Lacerda MV, Rueangweerayut R, Krudsood S, Gupta SK, Kochar SK, et al. Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study. Lancet. 2014;383:1049\u201358.","journal-title":"Lancet"},{"key":"2017_CR20","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1517\/13543784.16.5.705","volume":"16","author":"M Crockett","year":"2007","unstructured":"Crockett M, Kain KC. Tafenoquine: a promising new antimalarial agent. Expert Opin Investig Drugs. 2007;16:705\u201315.","journal-title":"Expert Opin Investig Drugs"},{"key":"2017_CR21","volume-title":"Point-of-care G6PD testing to support safe use of primaquine for the treatment of vivax malaria","author":"MPAC","year":"2015","unstructured":"MPAC. Point-of-care G6PD testing to support safe use of primaquine for the treatment of vivax malaria. Geneva: WHO; 2015."},{"key":"2017_CR22","volume-title":"Guidelines for the treatment of malaria","author":"WHO","year":"2015","unstructured":"WHO. Guidelines for the treatment of malaria. Geneva: World Health Organization; 2015."},{"key":"2017_CR23","doi-asserted-by":"publisher","first-page":"854","DOI":"10.4269\/ajtmh.14-0194","volume":"91","author":"N LaRue","year":"2014","unstructured":"LaRue N, Kahn M, Murray M, Leader BT, Bansil P, McGray S, et al. Comparison of quantitative and qualitative tests for glucose-6-phosphate dehydrogenase deficiency. Am J Trop Med Hyg. 2014;91:854\u201361.","journal-title":"Am J Trop Med Hyg"},{"key":"2017_CR24","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1186\/1475-2875-12-391","volume":"12","author":"GJ Domingo","year":"2013","unstructured":"Domingo GJ, Satyagraha AW, Anvikar A, Baird K, Bancone G, Bansil P, et al. G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests. Malar J. 2013;12:391.","journal-title":"Malar J"},{"key":"2017_CR25","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/j.1365-2141.1979.tb03774.x","volume":"43","author":"E Beutler","year":"1979","unstructured":"Beutler E, Blume KG, Kaplan JC, Lohr GW, Ramot B, Valentine WN. International Committee for Standardization in Haematology: recommended screening test for glucose-6-phosphate dehydrogenase (G-6-PD) deficiency. Br J Haematol. 1979;43:465\u20137.","journal-title":"Br J Haematol"},{"key":"2017_CR26","volume-title":"A guide to fluorescent spot testing for G6PD deficiency","author":"PATH","year":"2014","unstructured":"PATH. A guide to fluorescent spot testing for G6PD deficiency. Seatle: Programme for Appropriate Technology in Health; 2014."},{"key":"2017_CR27","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1186\/s12936-015-0896-8","volume":"14","author":"B Ley","year":"2015","unstructured":"Ley B, Luter N, Espino FE, Devine A, Kalnoky M, Lubell Y, et al. The challenges of introducing routine G6PD testing into radical cure: a workshop report. Malar J. 2015;14:377.","journal-title":"Malar J"},{"key":"2017_CR28","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1590\/0037-8682-0134-2016","volume":"49","author":"MA Brito","year":"2016","unstructured":"Brito MA, Peixoto HM, Almeida AC, Oliveira MR, Romero GA, Moura-Neto JP, et al. Validation of the rapid test Carestart(tm) G6PD among malaria vivax-infected subjects in the Brazilian Amazon. Rev Soc Bras Med Trop. 2016;49:446\u201355.","journal-title":"Rev Soc Bras Med Trop"},{"key":"2017_CR29","doi-asserted-by":"publisher","first-page":"e0148172","DOI":"10.1371\/journal.pone.0148172","volume":"11","author":"FE Espino","year":"2016","unstructured":"Espino FE, Bibit JA, Sornillo JB, Tan A, von Seidlein L, Ley B. Comparison of three screening test kits for G6PD enzyme deficiency: implications for its use in the radical cure of vivax malaria in remote and resource-poor areas in the Philippines. PLoS ONE. 2016;11:e0148172.","journal-title":"PLoS ONE"},{"key":"2017_CR30","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4269\/ajtmh.14-0298","volume":"92","author":"L Osorio","year":"2015","unstructured":"Osorio L, Carter N, Arthur P, Bancone G, Gopalan S, Gupta SK, et al. Performance of BinaxNOW G6PD deficiency point-of-care diagnostic-infected subjects. Am J Trop Med Hyg. 2015;92:22\u20137.","journal-title":"Am J Trop Med Hyg"},{"key":"2017_CR31","unstructured":"Green J. Tafenoquine & G6PD. \n                    http:\/\/sites.path.org\/dx\/files\/2012\/11\/01_Green_Tafenoquine.pdf\n                    \n                  : Glaxo Smith Kline; 2011. Power Point Presentation."},{"key":"2017_CR32","doi-asserted-by":"publisher","first-page":"e0169930","DOI":"10.1371\/journal.pone.0169930","volume":"12","author":"B Ley","year":"2017","unstructured":"Ley B, Alam MS, O\u2019Donnell JJ, Hossain MS, Kibria MG, Jahan N, et al. A Comparison of three quantitative methods to estimate G6PD activity in the Chittagong Hill tracts, Bangladesh. PLoS ONE. 2017;12:e0169930.","journal-title":"PLoS ONE"},{"key":"2017_CR33","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.16-0714","author":"TA Weppelmann","year":"2017","unstructured":"Weppelmann TA, von Fricken ME, Wilfong TD, Aguenza E, Philippe TT, Okech BA. Field trial of the CareStart biosensor analyzer for the determination of glucose-6-phosphate dehydrogenase activity in Haiti. Am J Trop Med Hyg. 2017. doi:\n                    10.4269\/ajtmh.16-0714\n                    \n                  .","journal-title":"Am J Trop Med Hyg"},{"key":"2017_CR34","volume-title":"Technical specifications series for submission to WHO prequalification: diagnostic assessment: in vitro diagnostics medical devices to identify glucose-6-phosphate dehydrogenase (G6PD) activity","author":"WHO","year":"2016","unstructured":"WHO. Technical specifications series for submission to WHO prequalification: diagnostic assessment: in vitro diagnostics medical devices to identify glucose-6-phosphate dehydrogenase (G6PD) activity. Geneva: World Health Organization; 2016."},{"key":"2017_CR35","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1369\/0022155415580594","volume":"63","author":"M Kahn","year":"2015","unstructured":"Kahn M, Ward WH, LaRue N, Kalnoky M, Pal S, Domingo GJ. Maintaining specimen integrity for G6PD screening by cytofluorometric assays. J Histochem Cytochem. 2015;63:454\u20138.","journal-title":"J Histochem Cytochem"},{"key":"2017_CR36","first-page":"5","volume":"26","author":"SA Ufelle","year":"2014","unstructured":"Ufelle SA, Neboh EE, Ocheni S, Ikekpeazu EJ, Maduka IC. The activity of glucose-6-phosphate dehydrogenase (G6PD) in stored blood. Orient J Med. 2014;26:5.","journal-title":"Orient J Med"},{"key":"2017_CR37","first-page":"155","volume":"15","author":"N Jalil","year":"2016","unstructured":"Jalil N, Azma RZ, Mohamed E, Ithnin A, Alauddin H, Baya SN, et al. Evaluation of glucose-6-phosphate dehydrogenase stability in stored blood samples. EXCLI J. 2016;15:155\u201362.","journal-title":"EXCLI J"},{"key":"2017_CR38","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1177\/000456329403100109","volume":"31","author":"GT Yuregir","year":"1994","unstructured":"Yuregir GT, Aksoy K, Arpaci A, Unlukurt I, Tuli A. Studies on red cell glucose-6-phosphate dehydrogenase: evaluation of reference values. Ann Clin Biochem. 1994;31:50\u20135.","journal-title":"Ann Clin Biochem"},{"key":"2017_CR39","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/1475-2875-12-286","volume":"12","author":"M Kahn","year":"2013","unstructured":"Kahn M, LaRue N, Bansil P, Kalnoky M, McGray S, Domingo GJ. Cryopreservation of glucose-6-phosphate dehydrogenase activity inside red blood cells: developing a specimen repository in support of development and evaluation of glucose-6-phosphate dehydrogenase deficiency tests. Malar J. 2013;12:286.","journal-title":"Malar J"},{"key":"2017_CR40","doi-asserted-by":"publisher","first-page":"818","DOI":"10.4269\/ajtmh.14-0696","volume":"92","author":"G Bancone","year":"2015","unstructured":"Bancone G, Chu CS, Chowwiwat N, Somsakchaicharoen R, Wilaisrisak P, Charunwatthana P, et al. Suitability of capillary blood for quantitative assessment of G6PD activity and performances of G6PD point-of-care tests. Am J Trop Med Hyg. 2015;92:818\u201394.","journal-title":"Am J Trop Med Hyg"},{"key":"2017_CR41","doi-asserted-by":"publisher","first-page":"e116143","DOI":"10.1371\/journal.pone.0116143","volume":"9","author":"A Roca-Feltrer","year":"2014","unstructured":"Roca-Feltrer A, Khim N, Kim S, Chy S, Canier L, Kerleguer A, et al. Field trial evaluation of the performances of point-of-care tests for screening G6PD deficiency in Cambodia. PLoS ONE. 2014;9:e116143.","journal-title":"PLoS ONE"},{"key":"2017_CR42","first-page":"1","volume":"366","author":"K Betke","year":"1967","unstructured":"Betke K, Beutler E, Brewer GJ, Kirkman HN, Luzzatto L, Motulsky AG, Ramot B, Siniscalco M. Standardization of procedures for the study of glucose-6-phosphate dehydrogenase. Report of a WHO Scientific Group. World Health Organ Tech Rep Ser. 1967;366:1\u201353.","journal-title":"World Health Organ Tech Rep Ser"},{"key":"2017_CR43","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/1475-2875-12-210","volume":"12","author":"M De Niz","year":"2013","unstructured":"De Niz M, Eziefula AC, Othieno L, Mbabazi E, Nabukeera D, Ssemmondo E, et al. Tools for mass screening of G6PD deficiency: validation of the WST8\/1-methoxy-PMS enzymatic assay in Uganda. Malar J. 2013;12:210.","journal-title":"Malar J"},{"key":"2017_CR44","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1046\/j.1365-3156.2003.01055.x","volume":"8","author":"IS Tantular","year":"2003","unstructured":"Tantular IS, Kawamoto F. An improved, simple screening method for detection of glucose-6-phosphate dehydrogenase deficiency. Trop Med Int Health. 2003;8:569\u201374.","journal-title":"Trop Med Int Health"},{"key":"2017_CR45","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/1475-2875-9-223","volume":"9","author":"M Kuwahata","year":"2010","unstructured":"Kuwahata M, Wijesinghe R, Ho MF, Pelecanos A, Bobogare A, Landry L, et al. Population screening for glucose-6-phosphate dehydrogenase deficiencies in Isabel Province, Solomon Islands, using a modified enzyme assay on filter paper dried bloodspots. Malar J. 2010;9:223.","journal-title":"Malar J"},{"key":"2017_CR46","doi-asserted-by":"publisher","first-page":"e0152304","DOI":"10.1371\/journal.pone.0152304","volume":"11","author":"NN Oo","year":"2016","unstructured":"Oo NN, Bancone G, Maw LZ, Chowwiwat N, Bansil P, Domingo GJ, et al. Validation of G6PD point-of-care tests among healthy volunteers in Yangon, Myanmar. PLoS ONE. 2016;11:e0152304.","journal-title":"PLoS ONE"},{"key":"2017_CR47","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0010-4825(00)00006-8","volume":"30","author":"A Mackinnon","year":"2000","unstructured":"Mackinnon A. A spreadsheet for the calculation of comprehensive statistics for the assessment of diagnostic tests and inter-rater agreement. Comput Biol Med. 2000;30:127\u201334.","journal-title":"Comput Biol Med"},{"key":"2017_CR48","unstructured":"Michael Kohn MSJ, Josh Senyak. Sample size calculators. University of California San Francisco; 2017. \n                    http:\/\/www.sample-size.net\/\n                    \n                  . Accessed 17 Mar 2017."},{"key":"2017_CR49","unstructured":"Rajasekhar Ramakrishnan SH. Biomath. Columbia University Medical Center, USA; 2017. \n                    http:\/\/biomath.info\/\n                    \n                  . Accessed 17 Mar 2017."},{"key":"2017_CR50","unstructured":"Dean AG, Sullivan KM, MM Soe, RA Mir. OpenEpi: open source epidemiologic statistics for public health. Emory University; 2003. \n                    http:\/\/www.openepi.com\n                    \n                  . Accessed 17 Mar 2017."},{"issue":"12 Suppl","key":"2017_CR51","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1038\/nrmicro1570","volume":"4","author":"S Banoo","year":"2006","unstructured":"Banoo S, Bell D, Bossuyt P, Herring A, Mabey D, Poole F, et al. Evaluation of diagnostic tests for infectious diseases: general principles. Nat Rev Microbiol. 2006;4(12 Suppl):S20\u201332.","journal-title":"Nat Rev Microbiol"},{"key":"2017_CR52","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/ilar.43.4.207","volume":"43","author":"RB Dell","year":"2002","unstructured":"Dell RB, Holleran S, Ramakrishnan R. Sample size determination. ILAR J. 2002;43:207\u201313.","journal-title":"ILAR J"},{"key":"2017_CR53","first-page":"507","volume":"10","author":"RA Fischer","year":"1915","unstructured":"Fischer RA. Frequency distribution of the values of the correlation coefficient in samples from an indefinitely large population. Biometrika. 1915;10:507\u201321.","journal-title":"Biometrika"},{"key":"2017_CR54","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/0197-2456(81)90001-5","volume":"2","author":"JM Lachin","year":"1981","unstructured":"Lachin JM. Introduction to sample size determination and power analysis for clinical trials. Control Clin Trials. 1981;2:93\u2013113.","journal-title":"Control Clin Trials"},{"key":"2017_CR55","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","volume":"1","author":"JM Bland","year":"1986","unstructured":"Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307\u201310.","journal-title":"Lancet"},{"issue":"12 Suppl","key":"2017_CR56","first-page":"S17","volume":"8","author":"S Banoo","year":"2010","unstructured":"Panel TDRDEE, Banoo S, Bell D, Bossuyt P, Herring A, Mabey D, et al. Evaluation of diagnostic tests for infectious diseases: general principles. Nat Rev Microbiol. 2010;8(12 Suppl):S17\u201329.","journal-title":"Nat Rev Microbiol"},{"key":"2017_CR57","unstructured":"Glucose-6-phosphate dehydrogenase deficiency. WHO Working Group. Bull World Health Organ. 1989;67:601\u201311."},{"key":"2017_CR58","first-page":"627","volume":"4","author":"K Hajian-Tilaki","year":"2013","unstructured":"Hajian-Tilaki K. Receiver operating characteristic (ROC) curve analysis for medical diagnostic test evaluation. Caspian J Int Med. 2013;4:627\u201335.","journal-title":"Caspian J Int Med"},{"key":"2017_CR59","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12936-017-1784-1","volume":"16","author":"K Thriemer","year":"2017","unstructured":"Thriemer K, Ley B, Bobogare A, Dysoley L, Alam MS, Pasaribu AP, et al. Challenges for achieving safe and effective radical cure of Plasmodium vivax: a round table discussion of the APMEN Vivax Working Group. Malar J. 2017;16:141.","journal-title":"Malar J"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-017-2017-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12936-017-2017-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-017-2017-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T07:19:03Z","timestamp":1589527143000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-017-2017-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,11]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2017"],"URL":"https:\/\/doi.org\/10.1186\/s12936-017-2017-3","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,11]]},"assertion":[{"value":"7 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"361"}}